chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Vaccine went into 2-8 °C thaw state on or about 24-Dec-2021 and administered on 16 Feb 2022; Vaccine went into 2-8 °C thaw state on or about 24-Dec-2021 and administered on 16 Feb 2022; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 °C thaw state on or about 24-Dec-2021 and administered on 16 Feb 2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 °C thaw state on or about 24-Dec-2021 and administered on 16 Feb 2022) in a 33-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 16-Feb-2022 at 8:52 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 16-Feb-2022 at 8:52 AM,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 °C thaw state on or about 24-Dec-2021 and administered on 16 Feb 2022). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 °C thaw state on or about 24-Dec-2021 and administered on 16 Feb 2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Vaccine went into 2-8 °C thaw state on or about 24-Dec-2021 and administered on 16 Feb 2022) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 °C thaw state on or about 24-Dec-2021 and administered on 16 Feb 2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications details were not reported by the reporter.  Vaccine went into 2-8 °C thaw state on or about 24-Dec-2021, this vaccine was administered up until its manufacturing expiry date of 4 April 2022.   Treatment details were not reported by the reporter.
On the 21st of January I had a bad cough.  I took a home COVID test and it came back positive. I went to the doctor, and they gave me Paxlovid and doxycycline to take for 10 days.  They also did another COVID test a rapid and a flu test.  They also did a chest x-ray due to my bad cough.  They thought I might have pneumonia as well, but I did not.  They COVID test came back positive.
This spontaneous report was received from a certified medical assistant (C.M.A.) concerning unspecified number of patients of unknown age and gender. No concurrent conditions or medical history were reported. On an unknown date, the patients were vaccinated with improperly stored doses of (Merck) VARIVAX (Lot # L006384 Expiration date: 25-FEB-2017) (doses, route and anatomical location of administration were not reported). No adverse events were reported. No Product Quality Complaint (PQC) was involved. This is one of several reports received from the same source. Additional information has been requested.
pneumonia; Flu; Initial information received on 05-Jan-2023 regarding an unsolicited valid Social Media serious case received from a consumer/non-hcp.  This case involves Adult and unknown gender patient who experienced pneumonia and flu after receiving Influenza vaccine.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.   On an unknown date, the patient received an unknown dose of suspect Influenza vaccine produced by unknown manufacturer (route, administration site, form, strength, dose, frequency, expiry date, lot number unknown) for Influenza.  On an unknown date the patient had developed pneumonia and flu (influenza) (unknown latency) following the administration of Influenza vaccine.   Action taken: not applicable.  It was not reported if the patient received a corrective treatment for the events (pneumonia, Flu).  Outcome: Unknown.  Seriousness criteria: medically significant for pneumonia.; Sender's Comments: Sanofi Company Comment dated 10-Jan-2023: This case involves a Adult and unknown gender patient who experienced pneumonia and flu after receiving Influenza vaccine. Based on the limited information provided regarding this case, causal role of the company suspect product cannot be excluded. However, lack of information of past and concomitant medication, any relevant medical history of patient, lab investigation and any concurrent conditions, therapy details precludes comprehensive case assessment.
Patient reports "hurting all over" as if she had the flu on day after vaccine. Says she had headache as well and these symptoms lasted 4-5 days before improving. Today is 7th day later and she still has a red spot/knot/area of swelling at the injection site that is fairly hard. It is making progress though.
for 2 weeks after vaccination had fever and trouble swallowing and eating  continues to still have trouble swallowing and eating
Administered second dose of Pfizer 5-11 to patient that turned 12 between doses.
Felt kind of wiped out; This case was reported by a pharmacist via call center representative and described the occurrence of worn out in an unspecified number of adult patients who received Herpes zoster (Shingrix) for prophylaxis.   On an unknown date, the patient received Shingrix at an unknown dose. On an unknown date, less than 2 years after receiving Shingrix, the patient experienced worn out. On an unknown date, the outcome of the worn out was unknown.   It was unknown if the reporter considered the worn out to be related to Shingrix.  Additional case details were provided as follows: The age group was not reported but was selected as an adult as per Shingrix indication. No patient identifiers to provide or lot number and expiry date. The reporter stated that, everyone she knew just felt kind of wiped out after receiving Shingrix dose and she heard this when she was just talking to nurses and other staff members. No further details were provided. The reporter did not consent to follow-up.
This spontaneous case reported by a pharmacist, describes the occurrence of illness (she got sick) and infection in a female patient, of an unknown age, who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On an unknown date, patient received the first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On an unknown date, patient experienced illness (she got sick) and infection. At the time of the report, illness (she got sick) and infection outcome: unknown. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. The reporter did not provide any causality assessments, concomitant medication or treatment information. Patient got sick at the time the second vaccine was supposed to be administered, so she never got it. She had some type of infection and was on antibiotics. Her physician recommended she not take the vaccine at that time.
Patient received Pfizer booster on 11/24/2021. From 11/25-11/27/2021, patient had progressively significant weakness ("especially in legs"). Fell 2x at home. Needed almost full assistance walking to the bathroom in the Emergency Dept. Neurologist consultation note on 12/1/2021 states: "Although he does have multilevel lumbar spinal stenosis and disc protrusions with a probable right L5 radiculopathy, his degree of weakness was felt to be significantly out of proportion to any objective abnormalities on his imaging. During the course of his hospitalization, his weakness has progressed to the point that he is unable to get up out of bed on his own. He has significant proximal bilateral lower extremity weakness. He also complains of some distal paresthesias, fingertips, and toes (starting on 11/27)."
pt recv vax 25JUL97 & on 9AUG97 pt exp a temp 99 & rash consisting of approx 40 to 50 papules on face, upper body, lt foot & leg;also 5 lesions were noted on rt arm;
5 months later I got Shingles on my Right upper thigh to my Right Glute area. I have not had the Shingles shot yet.
No adverse effects reported; expired dose of MMR II was administered; This spontaneous report was received from a health professional and refers to a patient of unknown age and gender. Concomitant therapies included sterile diluent (STERILE DILUENT). No information regarding the patient's pertinent medical history, drug reactions or allergies and concomitant therapies was provided.  On 29-AUG-2019, the patient was vaccinated with an expired dose of measles, mumps, and rubella (wistar ra 27-3) virus vaccine, live (rHA) (M-M-R II) lot # N020923, expiry date 01-AUG-2019 (exact dose and route of administration were not reported) for prophylaxis. No adverse effects were reported.  The outcome of expired product administered and no adverse event was unknown.
received the Pfizer Covid vaccine booster dose.; immunocompromised; feeling weak; fever; and "not feeling herself at all."; fallen ill; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team for a Pfizer sponsored program.  A 84 year-old female patient received bnt162b2 (BNT162B2) (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Bnt162b2 (1st Dose), for Covid-19 Immunization; Bnt162b2 (2nd Dose), for Covid-19 Immunization. The following information was reported: IMMUNISATION (medically significant), outcome "unknown", described as "received the Pfizer Covid vaccine booster dose."; IMMUNODEFICIENCY (medically significant), outcome "unknown", described as "immunocompromised"; ASTHENIA (non-serious), outcome "unknown", described as "feeling weak"; PYREXIA (non-serious), outcome "unknown", described as "fever"; FEELING ABNORMAL (non-serious), outcome "unknown", described as "and "not feeling herself at all.""; ILLNESS (non-serious), outcome "unknown", described as "fallen ill".  Clinical course: Caller states her 84 y/o aunt recently received the Pfizer Covid vaccine booster dose. She does not know the date but reports that after the booster dose she has been feeling weak, has a fever, and "not feeling herself at all." She wants to know what she can do to make sure she doesn't die. Patient took the third dose, the booster dose. Caller also referred to it as the second booster dose. Patient is immunocompromised. Patient has fallen ill.  Caller just doesn't know and doesn't want the patient to pass. Caller doesn't know if this is something temporary or if there's something she can do. Asking in the clinical trials if there are older people who have had the same symptoms? Asked if these older people passed away? Stated she has been transferred like 10 times now.   The lot number for bnt162b2 was not provided and will be requested during follow up.
Pain in arm; Fever; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Pain in arm) and PYREXIA (Fever) in a 49-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     The patient's past medical history included COVID-19 in December 2020.    On 01-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 01-Apr-2021, the patient experienced PAIN IN EXTREMITY (Pain in arm) and PYREXIA (Fever). At the time of the report, PAIN IN EXTREMITY (Pain in arm) and PYREXIA (Fever) had resolved. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant information were not reported. Treatment information were not reported.   Most recent FOLLOW-UP information incorporated above includes: On 05-Aug-2021: Follow up report received on 05 Aug 2021, Updated outcome for the events from unknown to recovered/resolved.
I had itching starting on my leg and it  has spread to my back. So much so that I have started peeling the skin off.
Pain in left shoulder at administration type. Diclofenac 75 mg BID x 30 days. Orthopedic consultation - pain continues.
This spontaneous report was received from a nurse practitioner regarding a patient of unknown age and gender. The patient's concurrent condition, medical history and concomitant medications were not reported. On 10-MAR-2009, patient received improperly stored (Oka/Merck) VARIVAX dose 1, from batch/lot # 61445/0525X (expiry date, dose units, route and anatomical location were not specified) (incorrect product storage). Concomitant medication were not reported. No adverse effects were reported. The reporter stated that inconsistencies in storage temperature were identified on extensive review and records. The reporter stated that vaccine was not thawed. The nurse practitioner reported that there was insufficient data to provided 100 percent assurance on vaccine stability. This is one of several reports received from the same reporter. Additional information has been requested.
No side effects reported. Mistakenly gave bivalent booster to a patient before primary series had begun
1 min after vaccination injected pt began complaining of severe pain in her left arm from injection site down to her hand. Pain peaked after 7-8 minutes and then stabilized. Feeling weakness in hand. Given ice pack, Motrin 400mg and Tylenol 500mg. Vitals stable. Exam nl, mild erythema at site which resolved after 15 min. Pt reported continued weakness in hand. But her exam was otherwise nl.
The day after receiving vaccines, patient developed a low-grade fever of 101 degrees and malaise. Patient experienced red, warm, swelling of right arm and was tender to touch. Patient contacted pharmacy 10/17 - was instructed to use cold pack and BENADRYL and monitor. If worsening in 24 hours or no improvement in 48 hours - instructed to see dr. Followed up on 10/20, swelling resolved, now just some soreness, No intervention needed.
Reports having her first COVID shot in March. She did well x 10 days then became very ill including nausea/vomiting/diarrhea. She received her 2nd COVID vaccine in early April. Developed the chills the night of the 2nd vaccine. Reports having to use the BR in the middle of the night and could not get out of bed. She reports to this day she feels her arms are "paralyzed." She has had labs and XR's of her shoulders. She was referred to Ortho. She was given an inj into the L shoulder and felt good x 1 day. Pain is worse on the L than the R. She requested an inj for the R as she cannot move her bilateral hands. Reports needing help with dressing, getting anything down from higher cabinets. CRP and Sed rate were very high per care everywhere. She was using Diclofenac but this was not helpful.  Now taking Gabapentin TID and Ibuprofen 800 mg almost every 6 hours. She cannot sleep on her sides. Not sleeping well as a result. Reports when she first wakes she cannot even lift her arms or brush her teeth. Has to shower x 20 min to move her arms. She does not want to blame the COVID vaccination but this started after receiving her 2nd vaccine She cannot tell if the Gabapentin is helping. She is very fatigued but cannot tell if this is r/t med or because she is not sleeping.  Denies travel, bug bites, tick bites.
received a vaccine which was more than 30 days in the refrigerator; vaccine which was more than 30 days in the refrigerator (30 days were on 03Jul2021).; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (received a vaccine which was more than 30 days in the refrigerator) and PRODUCT STORAGE ERROR (vaccine which was more than 30 days in the refrigerator (30 days were on 03Jul2021).) in an 81-year-old patient of an unknown gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 07-Jul-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 1. On 07-Jul-2021, the patient experienced EXPIRED PRODUCT ADMINISTERED (received a vaccine which was more than 30 days in the refrigerator) and PRODUCT STORAGE ERROR (vaccine which was more than 30 days in the refrigerator (30 days were on 03Jul2021).). On 07-Jul-2021, EXPIRED PRODUCT ADMINISTERED (received a vaccine which was more than 30 days in the refrigerator) and PRODUCT STORAGE ERROR (vaccine which was more than 30 days in the refrigerator (30 days were on 03Jul2021).) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medication was reported  No treatment medication was reported   This case was linked to MOD21-126929 (Patient Link).
The pt inadvertently received an intradermal injection of TD and subsequently developed an injection site reaction characterized by redness, swelling, itching, and induration. He was treated with topical steroid solution.
Fever (100.4), chills, body aches, headache, soreness at injection site. Alleviated with Tylenol. Symptoms resolved by 11pm on 2/15/21.
Swelling inside gums, throat area discomfort, blood pressure on entry 212/92
I had super high heart rates and high blood pressure after getting the vaccine and still do, my heart rate now sits around 130 BPM and when I went to the ER it was because I check my BP at home and it was 170/116 and I had no problems with blood pressure before the vaccine, I?m only 19 years old. now I can feel my heart flutter and times and I get really bad muscle pains like I have the flu at random times and I?m scared to get the 2nd dosage
12/8/08 - Rt shoulder tenderness, pain with motion, radiation of pain to wrist/hand - ACE wrap, ice or heat, IBUPROFEN, light duty at work 12/29/08 - worsening pain - ice, PREDINSONE burst 1/8/09 - Ice, IBUPROFEN, avoid painful motions 2/4/09 - Ultrasound - Slightly hypoechoic region apparently within the deltoid muscle. 3/4/09 - NSAIDS, pain medication, physical therapy
None.  I gave Pentacel inadvertently when I should have given Hib.  The parent was notified of mistake by Dr.  No actual adverse event - see attached - this was a report of an inadvertent use of PENTACEL instread of HIB.
Patient presented to the ED with complaints of intermittent fever and chills. He was found to be hypoxic, tachycardic and febrile. He was septic and subsequently admitted to the ICU. He was discharged to our inpatient rehabilitation center and still admitted there with ongoing treatment.
Severe body aches, severe chills, headache, nausea, extreme weakness. Started at night and  through out the night and is taking TYLENOL and Ibuprofen alternating, feeling a little better the next day. Patient refused any anti nausea medicine.
Redness, swelling (lump), itching, and warmth in area of injection.   Symptoms have continued a week plus after receiving vaccination
Severe headache on first night, with chills and sweats. On first morning after inoculation, rashes covered genitalia, spreading to several places (silver-dollar-sized rashes elsewhere). On evening of day after inoculation, facial swelling, including eyes and lips. At no time was there any problem with swallowing or breathing. On advice of physician, began 50mg of antihistamine Benadryl at night, with daytime antihistamine during day.
little bit dizzy; could not sleep; sweating; a little pain in the shoulder; nauseous; little bit of fever; felt a lot of burning from the injection site; loss of appetite; lots of muscle pain; a little headache; very tired; This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (little bit dizzy), INSOMNIA (could not sleep), HYPERHIDROSIS (sweating), ARTHRALGIA (a little pain in the shoulder) and NAUSEA (nauseous) in a 40-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 008B21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 29-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced DIZZINESS (little bit dizzy), INSOMNIA (could not sleep), HYPERHIDROSIS (sweating), ARTHRALGIA (a little pain in the shoulder), NAUSEA (nauseous), PYREXIA (little bit of fever), VACCINATION SITE PAIN (felt a lot of burning from the injection site), DECREASED APPETITE (loss of appetite), MYALGIA (lots of muscle pain), HEADACHE (a little headache) and FATIGUE (very tired). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form. At the time of the report, DIZZINESS (little bit dizzy), INSOMNIA (could not sleep), HYPERHIDROSIS (sweating), ARTHRALGIA (a little pain in the shoulder), NAUSEA (nauseous), PYREXIA (little bit of fever), VACCINATION SITE PAIN (felt a lot of burning from the injection site), DECREASED APPETITE (loss of appetite), MYALGIA (lots of muscle pain), HEADACHE (a little headache) and FATIGUE (very tired) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
A physician reported that an 11 month-old male received a 3rd dose of Prevnar and Infanrix vaccines on 14-JUN-2001, when he was 6-month-old. On 29-Nov-2001, the infant developed pneumococal bacteremia. Blood tests revealed "bacteremia" (without focus)" No additional information was available as of the date of this report This case was considered serious since septicemia streptococcal and drug ineffective were considered medically important in this case follow up information received 19-DEc-2001. Blood isolate from blood culture was serotype 22F (not a Prevnar vaccine serotype). The  patient was also reported to be "healthy and doing well'. Follow-up information received 04-JAN-2002 from physician. these events required an emergency room/ doctor visit the patient recovered.
positive covid test SARS-CoV-2 (COVID-19) by NAA, Micro  detected by routine screening when patient presented after trauma ( fall) to Emergency Center
Boostrix incomplete dose; vaccine run down the patient´s arm; vaccine run down the patient´s arm; This non-serious case was reported by a pharmacist via call center representative and described the occurrence of incomplete dose administered in a 42-year-old female patient who received DTPa (Reduced antigen) (Boostrix) (batch number HA9CH, expiry date 13-JUL-2025) for prophylaxis.   On 15-MAY-2023, the patient received Boostrix. On 15-MAY-2023, an unknown time after receiving Boostrix, the patient experienced incomplete dose administered (Verbatim: Boostrix incomplete dose), inadvertent exposure to vaccine (Verbatim: vaccine run down the patient´s arm) and exposure via skin contact (Verbatim: vaccine run down the patient´s arm). The outcome of the incomplete dose administered, inadvertent exposure to vaccine and exposure via skin contact were unknown.   Additional Information: GSK Receipt Date: 15-May-2023  The patient reported an incomplete dose of Boostrix was administered to a patient because of leakage during administration, which led to incomplete dose administered. PQC discarded because reporter mention the needle non supplied with the vaccine was split and cause the leakage. Reporter mentioned vaccine run down the patient´s arm, which led to inadvertent exposure to vaccine and exposure via skin contact. The reporter consented to follow up via email.
Painful (R) arm to shoulder, neck. Sore throat. Shaking fits. Fatigue. Vomiting. Diarrhea. Headache.